chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Child was given vaccine at approximately 1400 hrs.  About a minute later she started becoming pale.  She had a seizure-like episode with muscle rigidity and loss of bladder control. She did not appear to lose consciousness completely and was able to answer questions immediately after the episode.  We laid her down and applied cool towels to her face.  We gave her cool water to drink.  She became diaphoretic. Her breathing and pulse remained slow and regular.  She became well enough to sit up in a chair about 15 minutes after the episode, and I accompanied her to the car about 5 minutes later.  According to patient, the only thing she has eaten all day was a piece of bread.  She had never had a similar reaction to immunization, but her mother reported that many of her family members had either lost consciousness or become faint after immunization.  She also reported that patient has had low blood pressure in the past.  I called to check on her an hour later.  She had eaten and was acting normally.
Severe arm pain, enlarged lymph nodes. Severe headache. Body aches, chills
Localized allergic reaction affecting the left arm - given 25 mg Benadryl and observed 30 minutes for resolution.
within 5-10 minutes of injection, felt light-headed and fainted, support was with her and we helped her to the floor until stretcher could be moved over to her, immediately came to, placed on stretcher, rested for 10-15 minutes, drank water, felt well and got up from stretcher, no issues
Had fever like symptom 2 hours after shot, nausea, throat burning, chills which subsided the next morning. Redness and swelling at site of injection happened 2 hrs after. Bruising at site occurred later that night.
Patient reported limited range of motion in the vaccinated arm starting after the vaccine was given. Patient then reported that she felt very ill from 10/19/23 through 10/21/23. Starting on 10/21/23, patient developed a raised spot at site of injection and developed hives all over body, especially under arms. Patient went to local urgent care and was treated with benadryl for reaction management. As of 10/23, patient states they are doing good and symptoms resolved.
began experiencing neck and arm pain; hand and fingers felt tingly; a sharp pain in my arm and shoulder; a sharp pain in my arm and shoulder; hives forming all over, especially under my breasts and above my stomach; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 16Aug2021 16:00 (Lot number: FC3181) at the age of 39 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: NECK PAIN (non-serious) with onset 16Aug2021 16:00, outcome "not recovered", described as "began experiencing neck and arm pain"; PARAESTHESIA (non-serious) with onset 16Aug2021 16:00, outcome "recovering", described as "hand and fingers felt tingly"; PAIN IN EXTREMITY (non-serious), ARTHRALGIA (non-serious) all with onset 16Aug2021 16:00, outcome "not recovered" and all described as "a sharp pain in my arm and shoulder"; URTICARIA (non-serious) with onset 16Aug2021 16:00, outcome "not recovered", described as "hives forming all over, especially under my breasts and above my stomach". Therapeutic measures were not taken as a result of neck pain, paraesthesia, pain in extremity, arthralgia, urticaria.  Additional information included: It was reported that over the next few days patient's arm remained sore but the tingly decreased. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a healthcare worker refers to a 15 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 10-JUL-2015, the patient was vaccinated with an improperly stored dose of GARDASIL lot # K023432, expiration date 18-JUN-2016 (strength, dose and route of administration were not provided). There were no adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Acute onset of heart palpitations and chest discomfort around 0100 the day after receiving second Moderna Covid-19 vaccine. She presented initially to the Health Clinic and was transferred to Hospital emergency department with negative workup (see below). She was treated with 1L normal saline and 30mg of ketorolac in the ED with subsequent resolution of symptoms, and discharged home without recurrence of symptoms.
Fever; Nausea; Fatigue; Headache; Chills; Arm where got the vaccine is still red; Arm where got the vaccine has a little bit of swelling; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 08-Jan-2021, the patient experienced PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Fatigue), HEADACHE (Headache), CHILLS (Chills), VACCINATION SITE ERYTHEMA (Arm where got the vaccine is still red) and VACCINATION SITE SWELLING (Arm where got the vaccine has a little bit of swelling). In January 2021, PYREXIA (Fever), CHILLS (Chills), VACCINATION SITE ERYTHEMA (Arm where got the vaccine is still red) and VACCINATION SITE SWELLING (Arm where got the vaccine has a little bit of swelling) had resolved. At the time of the report, NAUSEA (Nausea), FATIGUE (Fatigue) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment medication included Paracetamol.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Tinnitus. I've gone two 2 ENT Doctors and tried accupuncture to resolve without success. The doctors have suggested suppliments (riboflavin, Ginko Biloba, Magnesium).
Patient received a vaccine on 10-Nov-2021  which had got expired on 09-Nov-2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine on 10-Nov-2021  which had got expired on 09-Nov-2021) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine on 10-Nov-2021  which had got expired on 09-Nov-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine on 10-Nov-2021  which had got expired on 09-Nov-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  It was reported that total of 168 doses were administered having Lot number as 048C21A.  The dates of administration were 10-Nov-2021 and 11-Nov-2021.  No information was reported on date of the storage of vaccine in refrigerator.  The vial did not undergo any temperature excursions.  Vaccine was expired on 09-Nov-2021.  Treatment information was not reported.  HCP administer expired vaccine to patients, after the manufacture date of expiration and wanted an assessments on the case.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow up received contains non-significant information-Additional Patient identifier were added.
Pt recvd 2nd dose Hep B 28MAR91 & on 4APR91 lower back & hip pain worsened; 3APR91 lab eval revealed inc SGPT levels; by 17APR91 pt had t103 & back pain; f/u 19APR91 showed inc levels of ESR, SGOT, GGT & Alkaline phos; weakness, h/a;
Arm swollen, red, warm to the touch at injection site, onset late the evening of 4/3/23, morning of 4/4/23.  Patient sought care at urgent care center after symptoms worsened and diagnosed with cellulitis the morning of 4/5/23.  Bactrim DS 800/160 twice daily for 10 days initiated 4/5/23.
pt recv vax;joint pains;fever 100.6;weakness,fatigue,swollen glands;painful swelling elbow;redness,tenderness;infect;erythematous elbow;purulent paronychia on 4th finger;dx: serum sickness muscles aches,backache,n;tx pred;
Red arm; Swollen arm; Arm angry and hot; Feeling Uncomfortable; A spontaneous report was received from an 82-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced red arm/erythema,swollen arm/peripheral swelling, angry,hot arm/ paraesthesia and feeling uncomfortable / discomfort.  The patient's medical history was not provided Concomitant product use was not provided/unknown by the reporter.  On 9 Jan 2021, prior to the onset of the events ,the patient received their first of two planned doses of mRNA-1273 (lot/batch: 011L20A)via unknown route  in the left arm for prophylaxis of COVID-19 infection.  On 17 Jan 2021, the patient experienced red ,swollen ,angry and hot arm and were feeling uncomfortable. Treatment included ice and cool damp rag.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of event ,swollen,hot arm and feeling uncomfortable were considered to be resolving.The outcome of the event, red arm was considered to be resolved.
Pt felt lightheaded after vaccination. Pt was brought into the medical room and lied on stretcher to rest. Pt initial vs were elevated for bp and hr. Pt was anxious. After 15-20 mins pt felt better and lightheadedness was gone. Pt vs were better and bp hr decreased to normal levels ( 138/87, 94). Pt was released. To observation area and pt checked out.
I seem to start coughing more in the next couple weeks and I hadn't done anything differently. I was tire that day My doctor recommended my pulmonologist. It got worse especially from the smoke in my enviroment.
t100.4 R; APAP given; pt was irritable, screamed, had drowsiness & dec feeding for a couple of days post vax; seen by neurologist; mild encephalopathy w/vax noted;
19 hrs later chills, fatigue, fever. 26 hours after sever pain under left arm and left side of breast.  Arm sore lymph?s feel swollen. Continuing into 48 hrs now
Redness of the left arm at site. Dehydration, hypotension, falls, confusion.
This spontaneous report was received from a physician refers to a 28 year old female patient. On 28-FEB-2013, the patient was vaccinated with GARDASIL lot # 0420AE, intramuscular (dose not reported0. On 05-MAR-2013, the patient developed prolonged arm pain and generalized burning pain in the right arm and shoulder, as well as a dull headache. The patient was treated with a NEURONTIN LIKE medication. There was no significant mobility loss in the right arm. The outcome of the events was unknown. The relatedness between the events and GARDASIL were unknown. Additional information is not expected.
SEVERE FLU LIKE SYMPTOMS LIKE (3 TO 4 TIMES TO NORMAL); VERY PAINFUL KIDNEY SPASMS THE SAME PAIN RANGE AS KIDNEY STONES; This spontaneous report received from a patient concerned an adult male. The patient's height, and weight were not reported. The patient's concurrent conditions included: impaired kidney function. The patient experienced drug allergy when treated with prochlorperazine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on OCT-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced severe flu like symptoms like (3 to 4 times to normal), and very painful kidney spasms the same pain range as kidney stones. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from severe flu like symptoms like (3 to 4 times to normal), and very painful kidney spasms the same pain range as kidney stones. This report was non-serious. This case, from the same reporter is linked to 20211039771.
PARTIAL DOSE ADMINISTERED; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on 16-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 16-MAR-2021, the subject experienced partial dose administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of partial dose administered was not reported. This report was non-serious.
Outbreak of rash/red welts and red/heat in the ears all over. Torso, scalp, arms, feet. This had occurred 3 times total every 3 -4  weeks since the first shot.
Febrile from 12/18-12/21 and then from 12/28-12/30. Emesis from day after vaccine (12/19) until 1/1 daily. First evaluated in our ER 12/29 and found to be encephalopathic with increased intracranial pressure. 1/6/10 Received hospital medical records for 12/30. FINAL DX: viral syndrome; meniningitic/encephalitis; Redman's syndrome. Records reveal patient experienced weakness & fever with seizure.  Initial fever started on 12/18, lasted 3-4 days.  Irritable.  Vomited daily x 2 wks.  After 1 wk emesis, seen in ER on 12/25, 26 & 27.  Dx w/otitis media & tx w/antibiotics (both oral & injectable).  Became progressively weaker until unable to stand w/o support.  Fever returned 12/29 & continued daily emesis & holding of head.  No BM x 5 days.  Weight loss, decreased urine output.  Exam revealed extensive weakness, unsteady gait, increased muscle tone & decreased reflexes.  LP done w/opening pressure >36(H).  Admitted.  Tx w/IVF, IV antibiotics, antivirals.  Neuro, ID, Ophtho, genetics consults done.  Developed mild drooping right eyelid & photophobia; macular erythematous pruritic rash.    1/20/10 Received hospital medical records 12/29/2009-1/8/2010. FINAL DX: pseudotumor cerebri, seizure disorder & anemia. Repeat LP done & continued to be elevated at 30, CSF WNL.  Tx w/diamox.  Gradually improved & d/c to home w/Neuro f/u.
Pt recvd 3 doses of Engerix-B p/3 doses test results were indeterminate; recvd 4th dose of Engerix-B 6FEB92; titer results pending
Patient reports that two to three days after his first shot he experienced a headache that lasted 5 days and has approximately 6 lesions on his left forearm and two on his left palm.  He treated the headache with acetaminophen and ibuprofen over 5 days.  He applied Neosporin to the lesions.
Patient presented to pharmacy 6/6/22 with red, itchy dots on R forearm. Rash appeared a couple days after Havrix administration. Pt treated with calamine lotion. RPh advised patient to use hydrocortisone instead.  Patient denied difficulty breathing. Patient stated he has upcoming appointment with provider and will have skin reaction evaluated by PCP at that time.
Sore on left side; Itching; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In MAR-2023, the patient received the 1st dose of Shingles vaccine (left arm). In MAR-2023, less than 2 weeks after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: Sore on left side) and pruritus (Verbatim: Itching). The outcome of the pain in arm and pruritus were not reported.   The reporter considered the pain in arm to be possibly related to Shingles vaccine. It was unknown if the reporter considered the pruritus to be related to Shingles vaccine.     The company considered the pain in arm to be possibly related to Shingles vaccine. It was unknown if the company considered the pruritus to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 13-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he/she received Shingles vaccine in last week in his or her left arm. The patient stated that when he or she sleep on his or her left side or he/she did then it was sore from the shot. The patient stated that this week he/she noticed some itching but still can not sleep on his/her left side maybe in another week. The patient reported that something to think about when you get your first shot. The patient stated that the he/she receive second dose is in six months and going to receive vaccine in the right arm next time. Follow-up would not possible as no contact details were available.
Severe HeAdAche , Chills , Fever over 101 Body Aches , Fitage   Second DAy 99.4
03/19/21 woke up with numbness on whole right side of body (head to toe). Referred to ER by Family Physician on 03/20/21. admitted to hospital for testing. MRI confirmed a blood clot caused a Lacuna Infarcts Event (type of mini stroke)  The patient continues to have numbness and difficulty walking, driving and has affected her normal daily activities. The patient will be required to start Plavix and baby aspirin.  Waiting for requirement for Prolong numbness which affects her daily activity.
almost die from it after I got the shot; Initial information was received on 10-Nov-2020 regarding an unsolicited valid non-serious social media case from the patient via Social medial.  This case involves a patient of unknown demographics who reported of dying from it after the shot (vaccination complication) while the patient received INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were not reported.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date, the patient who reported of dying from it after the shot (vaccination complication), (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  Corrective treatment was not reported.   The event outcome was unknown.  There will be no information available on the batch number for this case.
Case number PHEH2015US019682 is a combined initial and follow-up spontaneous report from a nurse received on 01 Oct 2015 and on 02 Oct 2015. This report refers to a 38 years old female patient. Past medical history and concomitant medications were not reported. Nurse reported that the patient was vaccinated with expired FLUVIRIN (batch number: 1413801, expiry date: Jun 2015) 0.5 ml intramuscular on 30 Sep 2015. No adverse event was reported. No further information was provided.
C/O pain in middle left arm since getting the vaccine back in October, no other symptoms. No treatment, did not report until today 3-13-18.
Dark bruise looking, hyperpigmentation around injection site that was 4 inches wide and 2 inches long that appeared 11 days after first dose
Student discovers a rash covering entire body. Began 24 hrs after the vaccine administration. Sought doctors diagnosis and treatment on day 4. Treated with Benadryl.
Swollen arm, internal swelling, fever  of 101 for over a week. Weakness, lethargy, redness of skin Visited primary Care Physician for symptoms, I didn?t relate to vaccine at the time, I was encouraged to report my symptoms. Arm is still tender after 5 weeks. Did not receive 2nd vaccine.
Narrative: 45 year old male with PMH of bilateral ankle surgeries for deep venous insufficiency, right arm superficial thrombophlebitis, MDD, GERD, and concussions presented to the ED for bilateral lower extremity pain. Patient received both doses of Pfizer. Findings were positive for bilateral DVTs in right calf and left groin. Patient was transfered back to Facility where he was started on therapeutic lovenox, IVF, and got a CTA. CTA was positive for multiple, small right sided PEs in segmental branches. Pt was observed in the hospital for one day.
Tachycardia: awoke me around 3am the evening after the injection, and lasted for about 24 hours. Felt feverish (hot/cold flashes) as well around 3am; this improved after awaking (6am) after taking Tylenol. Felt dizzier than normal (prior condition) upon getting out of bed the next morning, but was resolved within 24 hours.
felt under the weather for the first few days; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt under the weather for the first few days) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7170B) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (felt under the weather for the first few days). At the time of the report, MALAISE (felt under the weather for the first few days) outcome was unknown.      Concomitant medications were not reported.  The patient felt under the weather for the first few days, but otherwise patient was healthy and very fit. Treatment medications were not reported.
Narrative: Patient c/o of onset of headache, nausea today after 2nd Pfizer covid vaccine. Reported dizziness as she stood to ambulate to exam area. Pt reported this happened after 1st dose and was unable to work for 2 days after. Patient was monitored for another 15 minutes however was still dizzy upon standing. Patient was strongly recommended by physician assistant to go to ER via ambulance. However patient left AMA. Patient was able to make her primary care appointment 2 hours later.
This spontaneous report as received from a pharmacist refers to a now 49 years old female patient who was allergic to SULFA, erythromycin and latex. The patient had no pertinent medical history. The patient was vaccinated with ZOSTAVAX (lot # 672606/1655AA, expiration date 21-JAN-2013) on 02-JUL-2012. No other co-suspects were reported. No concomitant medications were reported. On 03-JUL-2012 the patient developed pain at the injection site and rash about 2 inches wide under the injection site. The patient had called the pharmacist for medical attention. No laboratory diagnostics studies or treatment were given. The outcome was unknown. Additional information has been requested.